Drug Profile
Research programme: PPAR pan-agonists for CNS disorders - Plexxikon
Latest Information Update: 07 Jul 2022
Price :
$50
*
At a glance
- Originator Plexxikon
- Class Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alzheimer's disease; Inflammatory bowel diseases; Multiple sclerosis; Parkinson's disease
Most Recent Events
- 06 Jul 2022 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route)
- 06 Jul 2022 Discontinued - Preclinical for Inflammatory bowel diseases in USA (unspecified route)
- 06 Jul 2022 Discontinued - Preclinical for Multiple sclerosis in USA (PO)